Infectious Diseases & Vaccines

Woman getting vaccinated by a doctor wearing blue gloves, representing infectious-disease-clinical-trials research.

FOMAT Prime Therapeutic Areas provide highly specialized research sites with robust infrastructure, experienced investigators, and proven recruitment models. In Infectious Diseases & Vaccines, we support trials targeting viral infections, bacterial diseases, and immunizations with advanced diagnostics and access to diverse populations

0

Patients accessible through EMR

0

Infectious Disease and Vaccine Sites with Full Capabilities

0 +

Diagnostic technologies fully integrated

0 %

Diverse patient enrollment

Infectious Diseases & Vaccines Trial Capabilities

Our infectious disease trial capabilities include state-of-the-art laboratory and testing equipment, experienced clinical research teams, and reliable operational support across all trial phases. We ensure consistent trial delivery with access to diverse pediatric and adult patient population

Full on-site diagnostic suite (PCR, ELISA, Flow Cytometry, Hematology Analyzers, Rapid Test Kits)

Dedicated SOPs and quality control processes for Digestive studies

Multi-location patient access across California research sites

Integrated EHR, CTMS, eSource, eConsent, and remote monitoring systems

Specialized community engagement and recruitment teams targeting pediatric, adult, and senior populations

Experienced research teams trained in infectious disease protocols and vaccine development

Key Differentiators

1

Reliable Start-Up Execution

Streamlined activation powered by experienced regulatory, legal, and start-up teams.

2

Experienced Infectious Disease Investigators

Board-certified PIs with proven track records in vaccine and infectious disease studies

3

Real-Time Data Management

Integrated digital systems ensure real-time data access, faster query resolution, and secure documentation

4

Comprehensive Recruitment & Retention

Targeted outreach and retention teams trained in engaging diverse communities and pediatric populations

5

Infrastructure for All Study Phases

Equipped to support early to late-phase trials with in-house labs, cryogenic storage, biosafety environments, and vaccine handling infrastructure

Specialized Sites for Infectious Disease & Vaccine Trials

Built to support complex immunization protocols and community-based research.